Description

Ethyl 1-Cyclohexyl-2-(Furan-3-Yl)-1H-Benzo[D]Imidazole-5-Carboxylate is a high-purity, advanced pharmaceutical intermediate characterized by its unique fused heterocyclic structure. This compound is of significant commercial interest for its role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly those targeting complex disease pathways. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in the development of new therapeutic agents, where consistent quality and reliable supply are paramount.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the multi-step synthesis of novel drug candidates, especially in oncology and antiviral research.
• Organic Synthesis Building Block: Used in medicinal chemistry for constructing complex benzimidazole-based molecular scaffolds with potential biological activity.
• Research & Development (R&D): Employed in academic and industrial R&D labs for structure-activity relationship (SAR) studies and lead optimization.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis projects under cGMP conditions.
• Chemical Reference Standard: Can be utilized as a high-purity analytical standard for method development and quality control in API production.

Basic Information

Product Name	Ethyl 1-Cyclohexyl-2-(Furan-3-Yl)-1H-Benzo[D]Imidazole-5-Carboxylate
CAS No.	871930-30-2
Molecular Formula	C20H22N2O3
Molecular Weight	338.40 g/mol
Synonyms	Ethyl 1-cyclohexyl-2-(3-furyl)-1H-benzimidazole-5-carboxylate; 1H-Benzimidazole-5-carboxylic acid, 1-cyclohexyl-2-(3-furanyl)-, ethyl ester; 871930-30-2; 1-Cyclohexyl-2-(furan-3-yl)-1H-benzo[d]imidazole-5-carboxylic acid ethyl ester; Ethyl 1-cyclohexyl-2-(furan-3-yl)-1H-benzo[d]imidazole-5-carboxylate
EINECS	Contact for details

Quality Control

Our production of Ethyl 1-Cyclohexyl-2-(Furan-3-Yl)-1H-Benzo[D]Imidazole-5-Carboxylate adheres to stringent quality management protocols to ensure batch-to-batch consistency and purity suitable for pharmaceutical R&D. All material is accompanied by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles. We support development projects with custom synthesis and purity grades upon request, ensuring compliance with your specific project requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to protect the compound from moisture.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 1.0%
Residual Solvents (GC)	Complies with ICH Q3C
Loss on Drying	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.